AdvocacyRSS4 days ago
A person with a muscular dystrophy explains how using a wheelchair has improved their quality of life and ability to participate in daily activities. Rather than viewing the wheelchair as a symbol of disability, they see it as a tool that gives them more independence and function. The article challenges common misconceptions about wheelchairs and disability.
WHY IT MATTERSThis perspective piece helps patients with muscular dystrophy and other mobility conditions understand that mobility aids like wheelchairs can expand independence rather than limit it, which may help reduce stigma and encourage earlier adoption of helpful devices.
AdvocacyRSS4 days ago
When muscular dystrophy makes it hard to work, you may qualify for disability benefits that provide money and health insurance. This article explains how to navigate the process of getting these public benefits so you don't lose financial stability. Understanding your options can help you manage living with MD while keeping some independence.
WHY IT MATTERSPeople with muscular dystrophy who can no longer work need to know how to access disability benefits and medical coverage to avoid financial hardship during disease progression.
AdvocacyRSS4 days ago
A mother of seven children shares her story about having three sons with Duchenne muscular dystrophy, a serious genetic muscle disease. She discusses her decision to have children despite knowing the genetic risks and explains why she doesn't regret her family planning choices. The article focuses on her perspective as both a caregiver and parent navigating life with this condition.
WHY IT MATTERSThis personal narrative highlights the lived experience and decision-making process for families with Duchenne muscular dystrophy, offering perspective on genetic counseling, family planning, and the emotional aspects of raising multiple children with the same rare disease.
ResearchRSS4 days ago
Researchers developed an artificial intelligence tool that can accurately detect bleeding inside joints in adults with hemophilia by analyzing ultrasound images. This technology could eventually allow patients to get ultrasound scans at home instead of traveling to a hospital or clinic. Early detection of joint bleeding is important because it helps prevent long-term damage to the joints.
WHY IT MATTERSHemophilia patients currently must travel to medical facilities for ultrasound imaging to detect joint bleeds; this AI tool could enable home-based monitoring, reducing travel burden and potentially catching bleeding episodes earlier.
NewsRSS4 days ago
This is a personal essay about someone's lifelong struggle with sleep, published on a hemophilia news website. The author describes how they've always found sleep difficult and treated it as optional, especially during high school. The article appears to be about learning better sleep habits, though the full content is cut off.
WHY IT MATTERSPeople with hemophilia often experience sleep disruption due to pain from joint bleeds and other complications, making sleep management strategies particularly relevant to this community.
NewsRSS4 days ago
A patient with Superior Mesenteric Artery Syndrome (SMAS) who had surgery is experiencing low iron levels (low ferritin), which is causing severe fatigue, brain fog, restless legs at night, and poor sleep. The article discusses how iron deficiency after SMAS surgery can make recovery harder and affect quality of life.
WHY IT MATTERSPatients recovering from SMAS surgery need to know that low ferritin levels are a treatable complication that directly causes the exhaustion and cognitive problems they may be experiencing post-operatively.
ResearchRSS4 days ago
Scientists studied how spinal muscular atrophy (SMA) damages the connections between nerves and muscles. They found that in people with SMA, these nerve-muscle connections don't develop properly right after birth, making them weak and unable to work well before nerve cells start dying. This early problem may be an important part of how SMA causes muscle weakness.
WHY IT MATTERSUnderstanding that nerve-muscle connection problems happen early in SMA—before nerve cell loss—could lead to new treatments that target this early stage rather than only treating later damage.
NewsRSS4 days ago
An adult with SMA (spinal muscular atrophy) who lives independently shares insights about how they built a caregiving team of over 20 volunteer friends instead of relying on paid professional caregivers. The article discusses strategies for finding and organizing friends to help with daily care needs, challenging the assumption that people with serious disabilities must use traditional caregiving services.
WHY IT MATTERSFor adults with SMA seeking independence, learning practical strategies to recruit and coordinate volunteer caregivers from your social network can make living on your own financially and socially sustainable.
NewsRSS4 days ago
The author shares their personal experience undergoing an overnight sleep study, comparing it to a previous study from 2002. They describe feeling nervous about the procedure but acknowledge that despite being uncomfortable, the study was necessary for their health. The article appears to be a patient perspective piece about the importance of sleep studies for diagnosis.
WHY IT MATTERSSleep studies are often critical diagnostic tools for patients with rare diseases like SMA (spinal muscular atrophy) that can affect breathing and sleep quality, making this firsthand account relevant to others considering or preparing for the same procedure.
ResearchRSS4 days ago
Scientists found that haloperidol, a medication normally used to treat psychiatric conditions, may help treat spinal muscular atrophy (SMA) by increasing levels of a protein called SMN that is missing or low in SMA patients. In laboratory tests with mouse cells and human patient cells, haloperidol helped nerve cells survive longer, reduced harmful inflammation, and improved movement. This suggests haloperidol could potentially be used alongside or instead of current SMA treatments.
WHY IT MATTERSIf haloperidol proves effective in human trials, SMA patients could potentially benefit from a medication that already exists and is FDA-approved, potentially offering a faster path to treatment than developing entirely new drugs.
NewsRSS4 days ago
A patient shares their experience moving from pediatric (children's) doctors to adult healthcare providers. The article describes the mixed feelings of relief and worry that come with this major life transition, using a waiting room scene to explore how gratitude and fear can happen at the same time.
WHY IT MATTERSTransitioning from pediatric to adult care is a critical moment for patients with rare diseases like SMA, where continuity of specialized treatment and emotional support can directly affect health outcomes and quality of life.
NewsRSS4 days ago
This is a personal story about a family who discovered they were expecting an unplanned baby in spring 1997. The parents and their 10-year-old son had to adjust to the news of a new family member on the way. The article appears to be part of a larger story about how this unexpected event connected to a rare disease.
WHY IT MATTERSThis article is from SMA News Today, suggesting it relates to spinal muscular atrophy (SMA), but the excerpt provided does not contain specific medical information, treatment details, or actionable health guidance for SMA patients.
Clinical trialRSS4 days ago
AB Science is preparing to test an experimental drug called masitinib for ALS (a disease that affects nerve cells that control muscles). To protect their investment in this large clinical trial, the company bought special insurance that would reimburse them if the trial doesn't go as planned or costs more than expected.
WHY IT MATTERSThis insurance arrangement signals that AB Science is confident enough in masitinib to move forward with Phase 3 testing in ALS patients, which is a critical step toward potentially bringing a new treatment option to people living with this progressive disease.
ResearchRSS4 days ago
A study of 34 patients in Hong Kong found that Evrysdi (a medicine taken by mouth) helped children and adults with spinal muscular atrophy (SMA) move better and feel better in their daily lives. Patients who had never taken SMA medicine before saw the biggest improvements. The good results lasted for up to three years.
WHY IT MATTERSThis real-world evidence from Asian patients shows Evrysdi works well outside of clinical trials, which may help doctors decide if it's the right treatment for SMA patients in your region.
NewsRSS4 days ago
This article discusses how people living with SMA (spinal muscular atrophy) can maintain healthy friendships with their caregivers, even when conflicts arise. The author emphasizes the importance of their caregiver community and explores ways to resolve disagreements while keeping these important relationships strong.
WHY IT MATTERSPeople with SMA depend on caregivers for daily support, making it crucial to know how to address conflicts constructively without damaging relationships that are essential to their health and independence.
AdvocacyRSS4 days ago
Delphine Andrews, a life coach and disability advocate from North Carolina who lives with SMA (spinal muscular atrophy), shared her personal story in a podcast interview. She discussed how she learned to accept herself, help others with disabilities, and build a career as a life coach. The episode also covered important topics like managing caregivers and understanding how different parts of someone's identity intersect.
WHY IT MATTERSHearing from someone living with SMA about practical strategies for self-acceptance, caregiver management, and career transition can help newly diagnosed patients and families navigate similar challenges in their own lives.
ResearchRSS4 days ago
Researchers found that a simple electrical test using surface electrodes on the skin can measure nerve signals in people with spinal muscular atrophy (SMA). These signals were much weaker in SMA patients compared to healthy people, which suggests this test could be a useful way to track how the disease changes over time.
WHY IT MATTERSIf validated, this non-invasive surface electrode test could provide a faster, easier, and cheaper way to monitor SMA progression in clinical trials and patient care compared to current muscle strength assessments.
ResearchRSS4 days ago
A large study in the UK followed over 500,000 people for about 10 years and found that breathing polluted air for a long time does not appear to increase the risk of getting ALS, a disease that affects nerve cells that control muscles. Fewer than 1,000 people in the study developed ALS during the study period. This suggests that air pollution may not be an important risk factor for developing ALS.
WHY IT MATTERSIf you have ALS or are worried about developing it, this study suggests that long-term air pollution exposure is unlikely to be a major cause, which may help reduce anxiety about environmental risk factors you cannot easily control.
ResearchRSS4 days ago
Scientists discovered that some people with ALS (a disease that affects nerve cells controlling muscles) may develop the condition from new mutations that happen by chance in their nerve cells, rather than inheriting the mutation from their parents. This is different from inherited ALS cases where a parent passes down a faulty gene. This finding suggests there are multiple ways ALS can develop, which could help doctors better understand and treat the disease.
WHY IT MATTERSIf your ALS diagnosis is sporadic (not inherited), this research suggests your condition may have developed from random mutations in your nerve cells rather than a genetic predisposition, which could change how doctors approach your treatment and genetic counseling.
ResearchPUBMED4 days ago
Researchers in France studied a group of patients with myasthenia gravis (a rare disease where muscles become weak and tired easily) who were treated at special centers between 2007 and 2021. They collected information about these patients' backgrounds, how their disease developed, and how long they lived. This study helps doctors understand more about this disease and how to care for patients better.
WHY IT MATTERSThis registry data provides real-world evidence about myasthenia gravis outcomes and patient characteristics in France, which can help identify gaps in care and inform treatment guidelines for MG patients across Europe.